This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Tirzepatide for metabolic dysfunction-associated steatohepatitis: results from phase II clinical trials and perspectives.
Expert opinion on investigational drugs, 34(9), 655-663
Citation
Fiorucci, Stefano; Urbani, Ginevra. (2025). Tirzepatide for metabolic dysfunction-associated steatohepatitis: results from phase II clinical trials and perspectives.. Expert opinion on investigational drugs, 34(9), 655-663. https://doi.org/10.1080/13543784.2025.2546812